20162 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON « prev | Page of 404 | next »
Genei Gene descriptioni x Evidencei x Tissuei Braini Single celli Subcelli Canceri Bloodi Cell linei Struct & Inti Prognostic p-valuei x
ABI2Abl interactor 2
Kidney Renal Clear Cell Carcinoma (TCGA): 6.96e-5
ABI3ABI family member 3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.90e-4
ABI3BPABI family member 3 binding protein
Kidney Renal Clear Cell Carcinoma (TCGA): 2.68e-7
ABITRAMActin binding transcription modulator
Kidney Renal Clear Cell Carcinoma (TCGA): 2.08e-4
Liver Hepatocellular Carcinoma (TCGA): 3.80e-4
ABL1ABL proto-oncogene 1, non-receptor tyrosine kinase
Kidney Renal Clear Cell Carcinoma (TCGA): 8.48e-5
ABL2ABL proto-oncogene 2, non-receptor tyrosine kinase
Breast Invasive Carcinoma (validation): 4.82e-5
ABLIM1Actin binding LIM protein 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.87e-7
Kidney Renal Clear Cell Carcinoma (validation): 2.47e-7
Pancreatic Adenocarcinoma (validation): 5.60e-4
ABLIM2Actin binding LIM protein family member 2
Lung Squamous Cell Carcinoma (validation): 1.25e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 4.98e-4
ABLIM3Actin binding LIM protein family member 3
Lung Squamous Cell Carcinoma (TCGA): 2.33e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 8.81e-5
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
Kidney Renal Clear Cell Carcinoma (TCGA): 6.30e-4
ABRABR activator of RhoGEF and GTPase
ABRAActin binding Rho activating protein
ABRACLABRA C-terminal like
Breast Invasive Carcinoma (TCGA): 9.47e-4
ABRAXAS1Abraxas 1, BRCA1 A complex subunit
Kidney Renal Clear Cell Carcinoma (TCGA): 3.20e-7
Kidney Renal Clear Cell Carcinoma (validation): 1.81e-4
Liver Hepatocellular Carcinoma (TCGA): 2.22e-4
ABRAXAS2Abraxas 2, BRISC complex subunit
Kidney Renal Clear Cell Carcinoma (TCGA): 7.63e-8
ABT1Activator of basal transcription 1
Kidney Renal Clear Cell Carcinoma (TCGA): 2.63e-4
Liver Hepatocellular Carcinoma (validation): 8.66e-4
ABTB1Ankyrin repeat and BTB domain containing 1
Kidney Renal Clear Cell Carcinoma (TCGA): 6.66e-4
ABTB2Ankyrin repeat and BTB domain containing 2
Lung Adenocarcinoma (TCGA): 9.28e-4
ABTB3Ankyrin repeat and BTB domain containing 3
Kidney Renal Clear Cell Carcinoma (TCGA): 2.40e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.68e-4
ACAA1Acetyl-CoA acyltransferase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 5.32e-11
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.41e-6
Kidney Renal Clear Cell Carcinoma (validation): 3.80e-4
Kidney Chromophobe (TCGA): 6.26e-4
ACAA2Acetyl-CoA acyltransferase 2
Kidney Renal Clear Cell Carcinoma (TCGA): 8.71e-12
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.27e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.77e-4
Uterine Corpus Endometrial Carcinoma (TCGA): 2.92e-4
Glioblastoma Multiforme (validation): 5.89e-4
ACACAAcetyl-CoA carboxylase alpha
Liver Hepatocellular Carcinoma (TCGA): 2.00e-6
ACACBAcetyl-CoA carboxylase beta
Kidney Renal Clear Cell Carcinoma (validation): 1.24e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.62e-5
Pancreatic Adenocarcinoma (TCGA): 9.75e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.10e-4
Thyroid Carcinoma (TCGA): 1.44e-4
ACAD10Acyl-CoA dehydrogenase family member 10
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.39e-4
ACAD11Acyl-CoA dehydrogenase family member 11
Kidney Renal Clear Cell Carcinoma (TCGA): 1.87e-8
ACAD8Acyl-CoA dehydrogenase family member 8
Kidney Renal Clear Cell Carcinoma (TCGA): 1.20e-11
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.35e-6
Pancreatic Adenocarcinoma (validation): 4.31e-4
ACAD9Acyl-CoA dehydrogenase family member 9
Kidney Renal Clear Cell Carcinoma (TCGA): 3.16e-7
ACADLAcyl-CoA dehydrogenase long chain
Kidney Renal Clear Cell Carcinoma (TCGA): 2.02e-9
Liver Hepatocellular Carcinoma (validation): 5.37e-7
Kidney Renal Clear Cell Carcinoma (validation): 4.42e-4
ACADMAcyl-CoA dehydrogenase medium chain
Kidney Renal Clear Cell Carcinoma (TCGA): 1.30e-13
Kidney Renal Clear Cell Carcinoma (validation): 1.48e-4
ACADSAcyl-CoA dehydrogenase short chain
Kidney Renal Clear Cell Carcinoma (TCGA): 2.34e-5
Glioblastoma Multiforme (validation): 3.69e-5
Pancreatic Adenocarcinoma (validation): 4.40e-5
Glioblastoma Multiforme (TCGA): 1.09e-4
Uterine Corpus Endometrial Carcinoma (TCGA): 1.09e-4
Liver Hepatocellular Carcinoma (TCGA): 2.06e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.61e-4
ACADSBAcyl-CoA dehydrogenase short/branched chain
Kidney Renal Clear Cell Carcinoma (TCGA): 3.83e-11
Kidney Renal Clear Cell Carcinoma (validation): 9.76e-5
Ovary Serous Cystadenocarcinoma (validation): 2.72e-4
Colon Adenocarcinoma (TCGA): 6.60e-4
ACADVLAcyl-CoA dehydrogenase very long chain
Kidney Renal Clear Cell Carcinoma (TCGA): 5.88e-8
Liver Hepatocellular Carcinoma (validation): 3.68e-4
ACANAggrecan
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.14e-9
ACAP1ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
Head and Neck Squamous Cell Carcinoma (TCGA): 1.77e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.18e-4
Lung Adenocarcinoma (TCGA): 7.51e-4
Breast Invasive Carcinoma (TCGA): 8.78e-4
ACAP2ArfGAP with coiled-coil, ankyrin repeat and PH domains 2
Kidney Renal Clear Cell Carcinoma (TCGA): 2.14e-4
Lung Adenocarcinoma (TCGA): 7.09e-4
ACAP3ArfGAP with coiled-coil, ankyrin repeat and PH domains 3
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.08e-5
Glioblastoma Multiforme (validation): 9.60e-4
ACAT1Acetyl-CoA acetyltransferase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.75e-11
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.62e-5
Liver Hepatocellular Carcinoma (validation): 3.37e-4
Liver Hepatocellular Carcinoma (TCGA): 5.79e-4
ACAT2Acetyl-CoA acetyltransferase 2
Breast Invasive Carcinoma (validation): 6.35e-5
ACBD3Acyl-CoA binding domain containing 3
Kidney Renal Clear Cell Carcinoma (TCGA): 4.28e-5
Lung Adenocarcinoma (validation): 1.04e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.56e-4
ACBD4Acyl-CoA binding domain containing 4
Kidney Renal Clear Cell Carcinoma (TCGA): 2.28e-6
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.63e-4
ACBD5Acyl-CoA binding domain containing 5
Kidney Renal Clear Cell Carcinoma (TCGA): 3.14e-8
Ovary Serous Cystadenocarcinoma (validation): 9.83e-4
ACBD6Acyl-CoA binding domain containing 6
ACBD7Acyl-CoA binding domain containing 7
ACCS1-aminocyclopropane-1-carboxylate synthase homolog (inactive)
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.67e-9
Glioblastoma Multiforme (TCGA): 2.59e-4
Lung Adenocarcinoma (TCGA): 7.30e-4
ACCSL1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like
ACDACD shelterin complex subunit and telomerase recruitment factor
Liver Hepatocellular Carcinoma (TCGA): 3.28e-5
Liver Hepatocellular Carcinoma (validation): 1.94e-4
ACEAngiotensin I converting enzyme
Kidney Renal Clear Cell Carcinoma (TCGA): 6.28e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.01e-4
ACE2Angiotensin converting enzyme 2
Kidney Renal Clear Cell Carcinoma (TCGA): 1.19e-10
ACER1Alkaline ceramidase 1
ACER2Alkaline ceramidase 2
Kidney Renal Clear Cell Carcinoma (TCGA): 6.52e-9
Kidney Renal Clear Cell Carcinoma (validation): 1.69e-6
« prev | Page of 404 | next »